IBDEI2UF ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,45353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45353,1,3,0)
 ;;=3^Cirrhosis of liver, unspec
 ;;^UTILITY(U,$J,358.3,45353,1,4,0)
 ;;=4^K74.60
 ;;^UTILITY(U,$J,358.3,45353,2)
 ;;=^5008822
 ;;^UTILITY(U,$J,358.3,45354,0)
 ;;=K75.9^^172^2265^26
 ;;^UTILITY(U,$J,358.3,45354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45354,1,3,0)
 ;;=3^Inflammatory liver disease, unspecified
 ;;^UTILITY(U,$J,358.3,45354,1,4,0)
 ;;=4^K75.9
 ;;^UTILITY(U,$J,358.3,45354,2)
 ;;=^5008830
 ;;^UTILITY(U,$J,358.3,45355,0)
 ;;=K85.90^^172^2265^29
 ;;^UTILITY(U,$J,358.3,45355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45355,1,3,0)
 ;;=3^Pancreatitis,Acute w/o Necrosis/Infection,Unspec
 ;;^UTILITY(U,$J,358.3,45355,1,4,0)
 ;;=4^K85.90
 ;;^UTILITY(U,$J,358.3,45355,2)
 ;;=^5138761
 ;;^UTILITY(U,$J,358.3,45356,0)
 ;;=K85.91^^172^2265^28
 ;;^UTILITY(U,$J,358.3,45356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45356,1,3,0)
 ;;=3^Pancreatitis,Acute w/ Uninfected Necrosis,Unspec
 ;;^UTILITY(U,$J,358.3,45356,1,4,0)
 ;;=4^K85.91
 ;;^UTILITY(U,$J,358.3,45356,2)
 ;;=^5138762
 ;;^UTILITY(U,$J,358.3,45357,0)
 ;;=K85.92^^172^2265^27
 ;;^UTILITY(U,$J,358.3,45357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45357,1,3,0)
 ;;=3^Pancreatitis,Acute w/ Infected Necrosis,Unspec
 ;;^UTILITY(U,$J,358.3,45357,1,4,0)
 ;;=4^K85.92
 ;;^UTILITY(U,$J,358.3,45357,2)
 ;;=^5138763
 ;;^UTILITY(U,$J,358.3,45358,0)
 ;;=K21.0^^172^2265^13
 ;;^UTILITY(U,$J,358.3,45358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45358,1,3,0)
 ;;=3^GERD w/ Esophagitis
 ;;^UTILITY(U,$J,358.3,45358,1,4,0)
 ;;=4^K21.0
 ;;^UTILITY(U,$J,358.3,45358,2)
 ;;=^5008504
 ;;^UTILITY(U,$J,358.3,45359,0)
 ;;=K20.0^^172^2265^7
 ;;^UTILITY(U,$J,358.3,45359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45359,1,3,0)
 ;;=3^Eosinophilic Esophagitis
 ;;^UTILITY(U,$J,358.3,45359,1,4,0)
 ;;=4^K20.0
 ;;^UTILITY(U,$J,358.3,45359,2)
 ;;=^336605
 ;;^UTILITY(U,$J,358.3,45360,0)
 ;;=K52.81^^172^2265^8
 ;;^UTILITY(U,$J,358.3,45360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45360,1,3,0)
 ;;=3^Eosinophilic Gastritis
 ;;^UTILITY(U,$J,358.3,45360,1,4,0)
 ;;=4^K52.81
 ;;^UTILITY(U,$J,358.3,45360,2)
 ;;=^5008702
 ;;^UTILITY(U,$J,358.3,45361,0)
 ;;=K52.82^^172^2265^6
 ;;^UTILITY(U,$J,358.3,45361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45361,1,3,0)
 ;;=3^Eosinophilic Colitis
 ;;^UTILITY(U,$J,358.3,45361,1,4,0)
 ;;=4^K52.82
 ;;^UTILITY(U,$J,358.3,45361,2)
 ;;=^336608
 ;;^UTILITY(U,$J,358.3,45362,0)
 ;;=I69.959^^172^2266^13
 ;;^UTILITY(U,$J,358.3,45362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45362,1,3,0)
 ;;=3^Hemiplegia/Hemiparesis Following Unspec Cerebrovascular Disease
 ;;^UTILITY(U,$J,358.3,45362,1,4,0)
 ;;=4^I69.959
 ;;^UTILITY(U,$J,358.3,45362,2)
 ;;=^5007563
 ;;^UTILITY(U,$J,358.3,45363,0)
 ;;=I10.^^172^2266^12
 ;;^UTILITY(U,$J,358.3,45363,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45363,1,3,0)
 ;;=3^HTN,Essential
 ;;^UTILITY(U,$J,358.3,45363,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,45363,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,45364,0)
 ;;=I20.9^^172^2266^1
 ;;^UTILITY(U,$J,358.3,45364,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45364,1,3,0)
 ;;=3^Angina pectoris, unspecified
 ;;^UTILITY(U,$J,358.3,45364,1,4,0)
 ;;=4^I20.9
 ;;^UTILITY(U,$J,358.3,45364,2)
 ;;=^5007079
 ;;^UTILITY(U,$J,358.3,45365,0)
 ;;=I21.3^^172^2266^16
 ;;^UTILITY(U,$J,358.3,45365,1,0)
 ;;=^358.31IA^4^2
